Adherence to omalizumab: A multicenter "real-world" study.

Campisi R, Crimi C, Intravaia R, Strano S, Noto A, Foschino MP, Valenti G, Viviano V, Pelaia C, Ricciardi L, Scichilone N, Crimi N

Open source

DOI
10.1016/j.waojou.2020.100103
Published
2020 Feb
Container
The World Allergy Organization journal
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.waojou.2020.100103,
  title = {Adherence to omalizumab: A multicenter "real-world" study.},
  author = {Campisi R and Crimi C and Intravaia R and Strano S and Noto A and Foschino MP and Valenti G and Viviano V and Pelaia C and Ricciardi L and Scichilone N and Crimi N},
  year = {2020},
  journal = {The World Allergy Organization journal},
  doi = {10.1016/j.waojou.2020.100103},
  url = {https://doi.org/10.1016/j.waojou.2020.100103}
}

RIS

TY  - JOUR
TI  - Adherence to omalizumab: A multicenter "real-world" study.
AU  - Campisi R
AU  - Crimi C
AU  - Intravaia R
AU  - Strano S
AU  - Noto A
AU  - Foschino MP
AU  - Valenti G
AU  - Viviano V
AU  - Pelaia C
AU  - Ricciardi L
AU  - Scichilone N
AU  - Crimi N
PY  - 2020
JO  - The World Allergy Organization journal
DO  - 10.1016/j.waojou.2020.100103
UR  - https://doi.org/10.1016/j.waojou.2020.100103
ER  - 

APA

R, C., C, C., R, I., S, S., A, N., MP, F., G, V., V, V., C, P., L, R., N, S., & N, C. (2020). Adherence to omalizumab: A multicenter "real-world" study.. The World Allergy Organization journal. https://doi.org/10.1016/j.waojou.2020.100103

Source records